• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

疫苗：文明的成就，人类的权利，我们未来的健康保障。

Vaccines: An achievement of civilization, a human right, our health insurance for the future.

机构信息

GlaxoSmithKline, Siena, Italy

Imperial College, Faculty of Medicine, London, UK.

出版信息

J Exp Med. 2019 Jan 7;216(1):7-9. doi: 10.1084/jem.20182160. Epub 2018 Dec 3.

DOI:10.1084/jem.20182160
PMID:30510147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6314523/
Abstract

Vaccines have made a key, cost-effective contribution to the prolongation of life expectancy and quality. Here we summarize challenges facing vaccinology and immunology at the level of society, scientific innovation, and technology in a global health perspective. We argue that vaccines represent a safety belt and life insurance for humankind.

摘要

疫苗在延长预期寿命和提高生活质量方面做出了关键的、具有成本效益的贡献。在此，我们从全球卫生视角出发，总结了疫苗学和免疫学在社会层面、科技创新层面所面临的挑战。我们认为，疫苗是人类的安全带和生命保险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1c7/6314523/6ee55d81675e/JEM_20182160_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1c7/6314523/6ee55d81675e/JEM_20182160_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1c7/6314523/6ee55d81675e/JEM_20182160_Fig1.jpg

相似文献

1
Vaccines: An achievement of civilization, a human right, our health insurance for the future.疫苗：文明的成就，人类的权利，我们未来的健康保障。
J Exp Med. 2019 Jan 7;216(1):7-9. doi: 10.1084/jem.20182160. Epub 2018 Dec 3.
2
Vaccinology: past achievements, present roadblocks and future promises.疫苗学：过去的成就、当前的障碍及未来的前景
Vaccine. 2003 Jan 30;21(7-8):593-5. doi: 10.1016/s0264-410x(02)00702-8.
3
Challenges of Developing Novel Vaccines With Particular Global Health Importance.具有特殊全球健康重要性的新型疫苗开发面临的挑战。
Front Immunol. 2020 Oct 14;11:517290. doi: 10.3389/fimmu.2020.517290. eCollection 2020.
4
Global Advisory Committee on Vaccine Safety, 11–12 December 2013.全球疫苗安全咨询委员会，2013年12月11日至12日。
Wkly Epidemiol Rec. 2014 Feb 14;89(7):53-60.
5
Global Advisory Committee on Vaccine Safety,12–13 June 2013.全球疫苗安全咨询委员会，2013年6月12日至13日。
Wkly Epidemiol Rec. 2013 Jul 19;88(29):301-12.
6
Decoding the human immune system to transform the future of global disease prevention and control.解码人类免疫系统，变革全球疾病预防与控制的未来。
Expert Rev Vaccines. 2016 Oct;15(10):1235-6. doi: 10.1586/14760584.2016.1170600. Epub 2016 May 25.
7
Resilience, Psychiatry and Religion from Public and Global Mental Health Perspective - Dialogue and Cooperation in the Search for Humanistic Self, Compassionate Society and Empathic Civilization.从公共与全球心理健康视角看复原力、精神病学与宗教——寻求人文自我、富有同情心的社会和共情文明中的对话与合作
Psychiatr Danub. 2017 Sep;29(3):238-244. doi: 10.24869/psyd.2017.238.
8
Vaccinology in the post-COVID-19 era.后 COVID-19 时代的疫苗学。
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2020368118.
9
The global vaccine enterprise: a developing world perspective.全球疫苗企业：发展中世界视角
Nat Med. 1998 May;4(5 Suppl):503-5. doi: 10.1038/nm0598supp-503.
10
Ethical and legal challenges of vaccines and vaccination: Reflections.
Indian J Med Ethics. 2017 Apr-Jun;2(2):72-74. doi: 10.20529/ijme.2017.019.

引用本文的文献

1
Understanding caregivers' and community influencers' perspectives on the barriers to childhood immunisation in Northern Nigerian States with public-private partnerships in routine immunisation programme.了解在尼日利亚北部各州的常规免疫计划中，通过公私伙伴关系，照顾者和社区有影响力的人士对儿童免疫接种障碍的看法。
BMC Public Health. 2025 Apr 21;25(1):1471. doi: 10.1186/s12889-025-22710-7.
2
Dissecting the properties of circulating IgG against streptococcal pathogens through a combined systems antigenomics-serology workflow.通过系统抗原组学-血清学联合工作流程剖析循环免疫球蛋白G针对链球菌病原体的特性。
Nat Commun. 2025 Feb 24;16(1):1942. doi: 10.1038/s41467-025-57170-5.
3

本文引用的文献

1
Phase 2b Controlled Trial of M72/AS01 Vaccine to Prevent Tuberculosis.M72/AS01 疫苗预防结核病的 2b 期对照试验。
N Engl J Med. 2018 Oct 25;379(17):1621-1634. doi: 10.1056/NEJMoa1803484. Epub 2018 Sep 25.
2
Molecular Signatures of Immunity and Immunogenicity in Infection and Vaccination.感染与疫苗接种中免疫和免疫原性的分子特征
Front Immunol. 2017 Nov 15;8:1563. doi: 10.3389/fimmu.2017.01563. eCollection 2017.
3
Immunization needs a technology boost.免疫接种需要技术提升。
Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F.
利用外膜蛋白A、C和F针对肯塔基沙门氏菌引起的非伤寒沙门氏菌病设计一种新型多表位疫苗候选物的免疫信息学研究
PLoS One. 2025 Jan 10;20(1):e0306200. doi: 10.1371/journal.pone.0306200. eCollection 2025.
4
A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens.病毒性疫苗防治猪病的理解与挑战综述
Viruses. 2024 May 24;16(6):833. doi: 10.3390/v16060833.
5
COVID-19 Vaccine Hesitancy among Parents of Children Younger than 12 Years: Experience from a Tertiary Outpatient Clinic.12岁以下儿童家长对新冠疫苗的犹豫态度：来自三级门诊的经验
Pharmacy (Basel). 2024 May 31;12(3):85. doi: 10.3390/pharmacy12030085.
6
Lessons Learned from the COVID-19 Vaccination Campaigns in Veneto Region: Population Vaccination Centers as Support for the Traditional Outpatient Model.从威尼托地区新冠疫苗接种运动中吸取的经验教训：人口疫苗接种中心对传统门诊模式的支持
Vaccines (Basel). 2023 Nov 7;11(11):1695. doi: 10.3390/vaccines11111695.
7
Factors in Vaccine Refusal by Patients Applying for COVID-19 PCR Test.申请新冠病毒核酸检测患者拒绝接种疫苗的相关因素。
Medeni Med J. 2023 Sep 28;38(3):193-203. doi: 10.4274/MMJ.galenos.2023.43959.
8
Vaccine Hesitancy Phenomenon Evolution during Pregnancy over High-Risk Epidemiological Periods-"Repetitio Est Mater Studiorum".孕期在高风险流行期间疫苗犹豫现象的演变——“重复是学习之母”
Vaccines (Basel). 2023 Jul 5;11(7):1207. doi: 10.3390/vaccines11071207.
9
Barriers, facilitators, and recommendations for childhood immunisation in Nigeria: perspectives from caregivers, community leaders, and healthcare workers.尼日利亚儿童免疫接种的障碍、促进因素和建议：来自照顾者、社区领导人和医疗保健工作者的观点。
Pan Afr Med J. 2022 Oct 25;43:97. doi: 10.11604/pamj.2022.43.97.35797. eCollection 2022.
10
Demographic Factors, Conspiracy Theories, and Beliefs Associated With COVID-19 Vaccine Hesitancy Among Pakistani Population: A Cross-Sectional Study.人口统计学因素、阴谋论以及与巴基斯坦民众对新冠疫苗犹豫态度相关的信念：一项横断面研究
Cureus. 2022 Dec 17;14(12):e32629. doi: 10.7759/cureus.32629. eCollection 2022 Dec.
Nature. 2017 Nov 16;551(7680):273. doi: 10.1038/d41586-017-05923-8.
4
CMV and natural killer cells: shaping the response to vaccination.巨细胞病毒和自然杀伤细胞：塑造对疫苗接种的反应。
Eur J Immunol. 2018 Jan;48(1):50-65. doi: 10.1002/eji.201646762. Epub 2017 Nov 8.
5
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.带状疱疹亚单位疫苗在 70 岁及以上成人中的疗效。
N Engl J Med. 2016 Sep 15;375(11):1019-32. doi: 10.1056/NEJMoa1603800.
6
Adaptation and memory in innate immunity.天然免疫中的适应性与记忆
Semin Immunol. 2016 Aug;28(4):317-8. doi: 10.1016/j.smim.2016.07.002.
7
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.2011 - 2020年低收入和中等收入国家儿童免疫接种的投资回报率
Health Aff (Millwood). 2016 Feb;35(2):199-207. doi: 10.1377/hlthaff.2015.1086.
8
History of vaccination.疫苗接种史。
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7. doi: 10.1073/pnas.1400472111. Epub 2014 Aug 18.
9
Seminars in Immunology. Technologies and opportunities for vaccines. Introduction.
Semin Immunol. 2013 Apr;25(2):87-8. doi: 10.1016/j.smim.2013.06.002. Epub 2013 Jul 10.
10
Tuberculosis vaccines: time to think about the next generation.结核病疫苗：是时候考虑下一代了。
Semin Immunol. 2013 Apr;25(2):172-81. doi: 10.1016/j.smim.2013.04.006. Epub 2013 May 21.